Home › Funds › JOHNSON & JOHNSON › NBTX

JOHNSON & JOHNSON position in NBTX

NANOBIOTIX · Health Care

JOHNSON & JOHNSON reported holding 5,623,816 shares of NBTX (NANOBIOTIX) in its Q3 2026 13F filing — a position valued at US$175.2M, representing 23.01% of its reported portfolio and ranking #2 among its reported holdings. JOHNSON & JOHNSON has disclosed NBTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)5.62M sh
Reported value held$175.24M
Portfolio Weight23.01%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How JOHNSON & JOHNSON's NBTX position evolved

JOHNSON & JOHNSON first disclosed a stake in NBTX in Q3 2023 at 959,637 shares (US$8.4M). The position peaked in Q2 2026 at 5,623,816 shares, worth US$212.0M. Across 13 filings, JOHNSON & JOHNSON increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 5,623,816 shares valued at US$175.2M. Notable position changes include a 486% increase in Q4 2023 (shares fell 31% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 959.64K $8.40M New
Q4 2023 5.62M $40.94M Add
Q1 2024 5.62M $36.55M Hold
Q2 2024 5.62M $28.12M Hold
Q3 2024 5.62M $32.34M Hold
Q4 2024 5.62M $16.14M Hold
Q1 2025 5.62M $20.13M Hold
Q2 2025 5.62M $25.45M Hold
Q3 2025 5.62M $106.23M Hold
Q4 2025 5.62M $130.02M Hold
Q1 2026 5.62M $173.61M Hold
Q2 2026 5.62M $212.02M Hold
Q3 2026 5.62M $175.24M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBTX and 13F data

NBTX (NANOBIOTIX) is a Health Care company. 20 other funds we track also report a position in NBTX. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBTX

No other tracked fund reports a position in NBTX.

All NBTX fund holders →

FAQ

How long has JOHNSON & JOHNSON held NBTX?

JOHNSON & JOHNSON has disclosed NBTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JOHNSON & JOHNSON's current position in NBTX?

As of Q3 2026, JOHNSON & JOHNSON holds 5.62M shares of NBTX (NANOBIOTIX), valued at $175.24M, representing 23.01% of its reported portfolio and ranking #2.

Has JOHNSON & JOHNSON been buying or selling NBTX?

In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in NBTX. The position peaked in Q2 2026 at 5.62M shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.